Skip Navigation


NDT Advance Access originally published online on November 16, 2004
Nephrology Dialysis Transplantation 2005 20(1):96-104; doi:10.1093/ndt/gfh563
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/1/96    most recent
gfh563v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Neumann, I.
Right arrow Articles by Meisl, F. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neumann, I.
Right arrow Articles by Meisl, F. T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant Vol. 20 No. 1 © ERA-EDTA 2004; all rights reserved

Original Article

Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis

Irmgard Neumann1, Renate Kain2, Heinz Regele2, Afschin Soleiman2, Sandra Kandutsch2 and Franz Thomas Meisl1

1 Department of Nephrology, Wilhelminenspital and 2 Department of Clinical Pathology, University of Vienna, Vienna, Austria

Correspondence and offprint requests to: Dr Neumann Irmgard, Wilhelminenspital, Department of Nephrology, Montleartstr. 37, A-1160 Vienna, Austria. Email: irmgard.neumann{at}nep.wil.magwien.gv.at

Background. Renal involvement remains a major determinant in antineutrophil cytoplasmic autoantibody-associated small vessel vasculitis (AASV). While some patients may develop persistent renal damage, others have a favourable outcome.

Methods. To identify patients at risk for poor renal outcome, we evaluated 95 renal biopsies (67 initial biopsies and 28 repeat biopsies) of 67 patients with AASV for the presence and extent of active (AI) and chronic (CI) lesions, retrospectively. AI, CI, levels of proteinuria and dose of cyclophosphamide (CYC) were related to renal outcome.

Results. Recovery of renal function in patients initially dialysis dependent was associated with a lower CI compared with patients who remained on dialysis (P<0.001), while AI did not differ significantly. In these patients, age <65 years revealed a positive predictive value of 85% for renal function recovery. Patients initially requiring dialysis exhibited a higher AI and CI compared with those who did not. Renal function in long-term follow-up correlated with CI and the amount of proteinuria. This relationship increased with time, exhibiting at 4 years a correlation coefficient of 0.607 for CI (P<0.01) and of 0.775 for proteinuria (P<0.001). Follow-up biopsies showed a more pronounced CI compared with initial biopsies (P<0.001). None of the investigated initial parameters was predictive for renal relapse. However, there was a relationship between dose and duration of CYC and time to relapse. Compared with the initial biopsy, repeat biopsies of eight patients with a creeping serum creatinine in clinical remission showed a decrease of AI (P<0.001) while CI increased rapidly. These patients also had less initial CYC (NS).

Conclusions. These data suggest that in AASV, evaluation of renal histopathology is helpful in predicting early and late renal outcome. Chronicity and proteinuria were the best determinants of poor renal prognosis. Activity may regress under therapy, while chronicity may progress despite treatment. The amount of CYC seems to influence the occurrence of early relapses and renal survival.

Keywords: ANCA; follow-up biopsies; glomerulonephritis; histopathology; prognosis; therapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 ANN INTERN MEDHome page
K. de Groot, L. Harper, D. R.W. Jayne, L. F. Flores Suarez, G. Gregorini, W. L. Gross, R. Luqmani, C. D. Pusey, N. Rasmussen, R. A. Sinico, et al.
Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody--Associated Vasculitis: A Randomized Trial
Ann Intern Med, May 19, 2009; 150(10): 670 - 680.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. A.F. de Lind van Wijngaarden, H. A. Hauer, R. Wolterbeek, D. R.W. Jayne, G. Gaskin, N. Rasmussen, L.-H. Noel, F. Ferrario, R. Waldherr, J. A. Bruijn, et al.
Chances of Renal Recovery for Dialysis-Dependent ANCA-Associated Glomerulonephritis
J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2189 - 2197.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. A.F. de Lind van Wijngaarden, H. A. Hauer, R. Wolterbeek, D. R.W. Jayne, G. Gaskin, N. Rasmussen, L.-H. Noel, F. Ferrario, R. Waldherr, E. C. Hagen, et al.
Clinical and Histologic Determinants of Renal Outcome in ANCA-Associated Vasculitis: A Prospective Analysis of 100 Patients with Severe Renal Involvement
J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2264 - 2274.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. K. Frankel, G. P. Cosgrove, A. Fischer, R. T. Meehan, and K. K. Brown
Update in the diagnosis and management of pulmonary vasculitis.
Chest, February 1, 2006; 129(2): 452 - 465.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
K. K. Brown
Pulmonary vasculitis.
Proceedings of the ATS, January 1, 2006; 3(1): 48 - 57.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.